Appropriateness of Antibiotic Combination Therapy for Severe Community-acquired Pneumonia in South Korea
Status:
NOT_YET_RECRUITING
Trial end date:
2027-02-01
Target enrollment:
Participant gender:
Summary
This study aims to provide high-level evidence for appropriate empirical antibiotic use tailored to the clinical reality in Korea by conducting a randomized controlled trial comparing monotherapy with piperacillin/tazobactam and combination therapy with piperacillin/tazobactam plus a fluoroquinolone in patients with severe community-acquired pneumonia.
Phase:
NA
Details
Lead Sponsor:
CHOSEOK YOON
Treatments:
Levofloxacin Piperacillin Piperacillin, Tazobactam Drug Combination Tazobactam